International Immunology, Vol. 13, No. 3, 305-312,
March 2001
© 2001 Japanese Society for Immunology
A potential role for protein tyrosine kinase p56lck in rheumatoid arthritis synovial fluid T lymphocyte hyporesponsiveness
1 Tolerance and Autoimmunity Section, INSERM U395, IFR 30, CHU Purpan, BP 3028, 31024 Toulouse Cedex 3, France
2 Molecular Immunology Unit, Institut Pasteur, 75724 Paris Cedex 15, France
3 Department of Rheumatology, Rangueil Hospital, 31403 Toulouse Cedex 4, France
4 Faculty of Life Sciences (UFR-SVT), University Toulouse III, 31062 Toulouse Cedex 4, France
Correspondence to: P. Romagnoli
Rheumatoid arthritis (RA) synovial fluid (SF)-T lymphocytes appear relatively inactive in situ and respond only weakly to diverse stimuli ex vivo. To characterize the molecular defects underlying this hyporesponsiveness we analyzed the expression level of several proteins involved in TCR-proximal signal transduction. As compared to peripheral blood (PB)-T lymphocytes, SF-T cells from some (but not all) of the patients analyzed expressed lower levels of TCR
ß, CD3
, TCR
, p56lck and LAT, while p59fyn, phospholipase C-
1 and ZAP-70 expression was unaltered. Semi-quantitative analysis of T cells from several patients revealed that the degree of TCR
chain and p56lck modulation correlated statistically significantly with the level of SF-T cell hyporesponsiveness. The differential reactivity of p56lck specific monoclonal and polyclonal antibodies in SF-T but not PB-T lymphocytes indicated that p56lck modulation consists of a conformational change rather than loss of expression. Our results indicate that multiple signaling molecules can be modulated in RA SF-T cells and show for the first time a direct quantitative correlation between T cell hyporesponsiveness and modulation of TCR
and of p56lck, a critical protein tyrosine kinase required for T cell activation.
Keywords: TCR
, LAT
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. L. Gorman, A. I. Russell, Z. Zhang, D. Cunninghame Graham, A. P. Cope, and T. J. Vyse Polymorphisms in the CD3Z Gene Influence TCR{zeta} Expression in Systemic Lupus Erythematosus Patients and Healthy Controls J. Immunol., January 15, 2008; 180(2): 1060 - 1070. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Uhlin, M. G. Masucci, and V. Levitsky Regulation of lck degradation and refractory state in CD8+ cytotoxic T lymphocytes PNAS, June 28, 2005; 102(26): 9264 - 9269. [Abstract] [Full Text] [PDF] |
||||
![]() |
E C Jury and P S Kabouridis T-lymphocyte signalling in systemic lupus erythematosus: a lipid raft perspective Lupus, June 1, 2004; 13(6): 413 - 422. [Abstract] [PDF] |
||||
![]() |
I. M. de Kleer, L. R. Wedderburn, L. S. Taams, A. Patel, H. Varsani, M. Klein, W. de Jager, G. Pugayung, F. Giannoni, G. Rijkers, et al. CD4+CD25bright Regulatory T Cells Actively Regulate Inflammation in the Joints of Patients with the Remitting Form of Juvenile Idiopathic Arthritis J. Immunol., May 15, 2004; 172(10): 6435 - 6443. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nervi, S. Nicodeme, C. Gartioux, C. Atlan, M. Lathrop, D. Reviron, P. Naquet, F. Matsuda, J. Imbert, and B. Vialettes No Association Between lck Gene Polymorphisms and Protein Level in Type 1 Diabetes Diabetes, November 1, 2002; 51(11): 3326 - 3330. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cemerski, A. Cantagrel, J. P. M. van Meerwijk, and P. Romagnoli Reactive Oxygen Species Differentially Affect T Cell Receptor-signaling Pathways* J. Biol. Chem., May 24, 2002; 277(22): 19585 - 19593. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. HASLER and M. ZOUALI B cell receptor signaling and autoimmunity FASEB J, October 1, 2001; 15(12): 2085 - 2098. [Abstract] [Full Text] [PDF] |
||||





